论文部分内容阅读
目的:探讨银杏达莫治疗急性脑梗死的疗效和不良反应。方法:对收治的急性脑梗塞84例患者,按随机数字表法分为治疗组和对照组,对照组42例予常规治疗,治疗组42例在对照组治疗基础上加用银杏达莫治疗,观察两组临床疗效及神经功能缺损评分情况。结果:治疗组总有效率为95.2%,明显高于对照组的85.7%(P<0.05),且治疗组治疗后的神经功能缺损评分(NIHSS)明显低于对照组(P<0.05),BI评分则明显高于对照组(P<0.05),两组均未见严重不良反应。结论:银杏达莫是治疗急性脑梗死安全、有效的药物。
Objective: To investigate the efficacy and adverse reactions of gingko dipyridamole in the treatment of acute cerebral infarction. Methods: A total of 84 patients with acute cerebral infarction were randomly divided into treatment group and control group according to random number table. In the control group, 42 patients were given routine treatment. In the treatment group, 42 patients were treated with gingko-damo in the control group, The clinical efficacy and neurological deficit score of the two groups were observed. Results: The total effective rate of the treatment group was 95.2%, significantly higher than that of the control group (85.7%, P <0.05), and the NIHSS of the treatment group was significantly lower than that of the control group (P <0.05) The score was significantly higher than the control group (P <0.05), no serious adverse reactions in both groups. Conclusion: Ginkgo biloba is safe and effective in the treatment of acute cerebral infarction.